Japan· JP-3222405A1026
デルイソマルトース第二鉄
A medicinal product containing デルイソマルトース第二鉄, registered in Japan by 日本新薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- デルイソマルトース第二鉄
- Manufacturer
- 日本新薬
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
デルイソマルトース第二鉄 in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumDiafer 50 mg/mlPharmacosmos
- SwedenDiafer 50 mg/ml Injektionsvätska, lösningPharmacosmos A/S
- United KingdomDiafer 100mg/2ml solution for injection ampoulesPharmacosmos UK Ltd
- United StatesMonoferricPharmacosmos Therapeutics Inc.
- NorwayDiaferPharmacosmos
- NetherlandsDiafer 50 mg/ml oplossing voor injectiePharmacosmos A/S
- PolandDiaferPharmacosmos A/S
- FinlandDiaferPharmacosmos A/S
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Monofer
- Belgium · Monoferric
- Bulgaria · Монофер
- Germany · Monofer
- Denmark · Diafer, Monofer
- Estonia · Monofer
- Finland · Diafer, Monofer
- United Kingdom (Northern Ireland) · Diafer, Monofer
- Croatia · Monofer
- Ireland · Diafer, Monover
- Iceland · Monofer
- Italy · Monoferric
- Lithuania · Monofer
- Luxembourg · Monover
- Latvia · Monofer
- Netherlands · Diafer, Monofer
- Norway · Diafer, Monofer
- Poland · Diafer, Monover
- Portugal · Monofar
- Romania · Diafer, Monofer
- Sweden · Diafer, Monofer
- Slovenia · Monofer
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fcddfaad-aa76-4cce-b386-061f92c3f899 GET /v1/drugs/fcddfaad-aa76-4cce-b386-061f92c3f899?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５００ｍｇ５ｍＬ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3222405A1026",
"category": "注射薬",
"price_yen": 6176,
"generic_name": "デルイソマルトース第二鉄",
"product_name_jp": null,
"therapeutic_class": "3222",
"transitional_expiry": null
}See everything about デルイソマルトース第二鉄.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.